Literature DB >> 8439902

Lovastatin and cholestasis.

E M Yoshida, A Levin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8439902      PMCID： PMC1490466     

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  4 in total

1.  Lovastatin-induced hepatitis.

Authors:  D Raveh; R Arnon; A Israeli; S Eisenberg
Journal:  Isr J Med Sci       Date:  1992-02

2.  [Cholestatic jaundice during lovastatin medication].

Authors:  U Spreckelsen; R Kirchhoff; H Haacke
Journal:  Dtsch Med Wochenschr       Date:  1991-05-10       Impact factor: 0.628

3.  Cholestatic jaundice associated with lovastatin (mevacor) therapy.

Authors:  J A Geddes
Journal:  CMAJ       Date:  1990-07-01       Impact factor: 8.262

4.  Cholestatic jaundice associated with lovastatin (Mevacor) therapy.

Authors:  M J McQueen
Journal:  CMAJ       Date:  1990-04-15       Impact factor: 8.262
  4 in total
  1 in total

Review 1.  Statin adverse effects : a review of the literature and evidence for a mitochondrial mechanism.

Authors:  Beatrice A Golomb; Marcella A Evans
Journal:  Am J Cardiovasc Drugs       Date:  2008       Impact factor: 3.571
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.